Cuzick J. IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole. Expert Rev Anticancer Ther 2008;8:1377-85.Cuzick J. IBIS II: a breast cancer prevention trial in postmenopausal women using the aromatase inhibitor anastrozole [ J] . Expert Rev...
One study of the preventive effects of an aromatase inhibitor has been done in high-risk women without breast cancer: in the MAP.3 trial,8 exemestane was compared with placebo in postmenopausal women. Exemestane significantly reduced the incidence of all breast cancer by 53% and invasive breast ...
药品品类市场洞察系统(企) 全球畅销药品销售数据 生物制品销售数据 上市企业销售数据 战略 投资格局(企) 政策法规 准入 药品中标 国家药品集中带量采购 其他 全国医院 全球流行病学分析系统(企) 原料药用量(企) 药品最高零售价(1996-2015) 低价药目录
Intra‐arterial bone marrow mononuclear cells (BM‐MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a phase II, randomized, dose‐f... (2015) Intra-arterial bone marrow mononuclear cells (BM-MNCs) transplantation in acute ischemic stroke (IBIS trial): protocol of a ...
Aromatase Inhibitors in Breast Cancer Prevention: IBIS-Trial IINo AbstractCuzick, J.EUROPEAN JOURNAL OF CANCER -SUPPLEMENT-
Methods IBIS-II is an international, randomised, double-blind, placebo-controlled trial. Postmenopausal women at increased risk of developing breast cancer were recruited and were randomly assigned (1:1) to either anastrozole (1 mg per day, oral) or matching placebo daily for 5 years. After ...
The Results of the IBIS II TrialCharles L. Shapiro, MD
Knox, S. Cawthorn, et al., Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo- controlled trial, Lancet 383 (9922) (2014) 1041-1048.Cuzick J, Sestak I, Forbes JF, et al: Anas- trozole for ...
Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). The Lancet Oncology 9, 953e961.Jenkins VA, Ambroisine LM, Atkins L, et al. Effects of anas- trozole on cognitive performance in postmenopausal women: a randomised...
Knox, S. Cawthorn, et al., Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo- controlled trial, Lancet 383 (9922) (2014) 1041-1048.Cuzick, J., Sestak, I., Forbes, J.F., et al. (2014). ...